KINIKSA PHARMACEUTICALS INTE

Kiniksa Insider Drama: Quart Barry D’s Zero‑Price Gift Sale Sparks Investor Frenzy and Questions Over Future Moves

Quart Barry D’s gift sale of 2,600 Kiniksa shares signals insider confidence amid volatile sentiment and rising social‑media buzz.

KINIKSA PHARMACEUTICALS INTE
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

21/08/2026, 22:51

3 minutes to read

Levy Richard S Buys More KINIKSA Shares, Signaling Insider Confidence Amid High‑Beta Volatility

Levy Richard S’s latest buy of KINIKSA Pharma shares signals insider confidence—an insider‑buy trend worth watching for investors.

KINIKSA PHARMACEUTICALS INTE
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

04/08/2026, 23:11

3 minutes to read

Cole G. Bradley Sells $299K of KINIKSA Shares—Charitable Gift or Portfolio Rebalance?

Insider sale at Kiniksa Pharmaceuticals: Cole G. Bradley sells 3,673 Class A shares for $81.43 each, framed as a charitable gift, showing prudent portfolio rebalancing while the stock continues its strong rally.

KINIKSA PHARMACEUTICALS INTE
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

31/07/2026, 22:54

3 minutes to read